1st Quarter - Report

BAXTER HEALTHCARE CORPORATION for BAXTER HEALTHCARE CORPORATION

Firm
Client
Income
—
Expenses
$970,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

The Miscellaneous Tariff Bill

LobbyistCovered position, as disclosed
JOSEPH V SCHWAN Deputy Chief of Staff, U.S. Dept of Commerce

Contacted: State, Dept of (DOS); SENATE; Centers For Medicare and Medicaid Services (CMS); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC)

Medicare/Medicaid MMM

H.R. 3200: To provide affordable, quality health care for all Americans and reduce the growth in health care spending. H.R. 4872: The Health Care and Education Reconciliation Act. S. 301: A bill to amend title XI of the Social Security Act to provide for transparency in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid or SCHIP. H.R.1765: To amend title XVIII of the Social Security Act with respect to payment for the furnishing of intravenous immune globulin (IVIG) in a patient's home for the treatment of primary immune deficiency diseases and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare Program. S.701: A bill to amend title XVIII of the Social Security Act to improve access of Medicare beneficiaries to intravenous immune globulins (IVIG). S. 1796/H.R. 3200: America's Healthy Future Act, as it relates to Medicaid reimbursement for drugs and new fees on manufacturers of drugs and medical devices.

LobbyistCovered position, as disclosed
SARAH CREVISTON —
JACK MANIKO Counsel, House Cmte on Energy & Commerce
KELLI MILLS LESTER —
JED PERRY —
JOSEPH V SCHWAN Deputy Chief of Staff, U.S. Dept of Commerce
DEBORAH WILLIAMS —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC)

Bills named: H.R. 3200 (111th), S. 701 (111th), S. 301 (111th), H.R. 4872 (111th), H.R. 1765 (111th), S. 1796 (111th)

Taxation/Internal Revenue Code TAX

H.R. 3200/S. 1796, America's Affordable Health Choices Act of 2009: "America's Healthy Future Act", as it relates to new fees on manufacturers of drugs and medical devices and to taxation of employer-sponsored health coverage. Issues related to the taxation of foreign earnings of U.S. multinational corporations

LobbyistCovered position, as disclosed
JACK MANIKO Counsel, House Cmte on Energy & Commerce
JED PERRY —
JOSEPH V SCHWAN Deputy Chief of Staff, U.S. Dept of Commerce

Contacted: Natl Economic Council (NEC); Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 1796 (111th), H.R. 3200 (111th)

Copyright/Patent/Trademark CPT

S.515/S. 610/H.R. 1260: Patent Reform Act of 2009, all issues related to patent reform.

LobbyistCovered position, as disclosed
JED PERRY —
JOSEPH V SCHWAN Deputy Chief of Staff, U.S. Dept of Commerce

Contacted: HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); SENATE; Homeland Security, Dept of (DHS)

Bills named: S. 515 (111th), S. 610 (111th), H.R. 1260 (111th)

Health Issues HCR

H.R. 3200/S. 1796: To provide affordable, quality health care for all Americand and reduce the growth in health care spending. H.R. 3590: The Patient Protection Affordable Care Act. H.R. 4872: The Health Care and Education Reconciliation Act. H.R. 3962: To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes. H.R. 2726: To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. H.R. 759, the FDA Globalization Act, as it relates to drug safety and pedigree. 340B drug discount program Drug and device marketing and promotion Drug and biological product pricing and reimbursement Follow-on biologics Healthcare-acquired infections Health insurance reform Implementation of bundling provisions in H.R. 6331(110th Congress) Issues regarding 340B Medical product safety Prescription drug pedigree and anti-counterfeiting policy

LobbyistCovered position, as disclosed
SARAH CREVISTON —
JACK MANIKO Counsel, House Cmte on Energy & Commerce
KELLI MILLS LESTER —
JED PERRY —
JOSEPH V SCHWAN Deputy Chief of Staff, U.S. Dept of Commerce
DEBORAH WILLIAMS —

Contacted: State, Dept of (DOS); SENATE; Homeland Security, Dept of (DHS); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3590 (111th), H.R. 2726 (111th), S. 1796 (111th), H.R. 4872 (111th), H.R. 759 (111th), H.R. 3962 (111th), H.R. 6331 (111th), H.R. 3200 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.